EP3568204
PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.1.2018:
30.8.2023:
18701574.8
:
7.1.2038
:
PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITOR
8.1.2018
30.8.2023
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITAL:
55 Fruit Street, Boston, MA 02114, US
:
DARDAEI ALGHALANDIS, Leila:
Cambridge, Massachusetts 02139, US
:
ENGELMAN, Jeffrey Adam:
Cambridge, Massachusetts 02139, US
:
HAO, Huaixiang:
Cambridge, Massachusetts 02139, US
:
LI, Fang:
Arlington, Massachusetts 02476, US
:
LAMARCHE, Matthew J.:
Cambridge, Massachusetts 02139, US
:
WANG, Hui-Qin:
Cambridge, Massachusetts 02139, US
:
201762444493 P:
10.1.2017:
US
:
IB2018050111:
8.1.2018
:
A61K 31/4353, A61P 35/00, A61K 45/06, A61K 31/4439, A61K 31/506, A61K 31/513, A61K 31/519, A61K 31/53, A61K 31/5375